About this trial

Photobiomodulation Group (Intervention Group):

Before the intervention, the patient's skin sensitivity to light will be tested by applying light for 3 minutes to one-fourth of the forearm skin. If redness occurs and persists for more than 2 hours, this indicates photosensitivity, and the intervention will not be performed.

The Patient Information Form will be completed during the first meeting with the patients included in the study. Subsequently, blood values will be determined, the Patient Assessment Form will be filled out, vital signs will be measured, and then the intervention will begin. After routine wound care/cleaning procedures in the intensive care unit, without applying any medication, cream, or lotion to the wound area, red light (660 nm wavelength) will be applied to the wound area for 5 minutes at a distance of 55 cm during the first 3 days, and for 10 minutes at the same distance on the following days. This application will continue once daily for 14 days. Wound assessments will be performed, and photographs will be taken on Day 1, Day 4, Day 7, and Day 14 (Baracho et al., 2021; Viecelli et al., 2024; Lima et al., 2020).

Control Group:

The Patient Information Form will be completed during the first meeting with the patients included in the study. Subsequently, blood values will be determined, the Patient Assessment Form will be filled out, and vital signs will be measured. No intervention will be performed other than the routine wound care procedure carried out in the intensive care unit. Wound assessments will be performed, and photographs will be taken on Day 1, Day 4, Day 7, and Day 14, in the same manner as in the intervention group.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients with Stage II pressure ulcers

Patients without any skin disease

Patients with albumin, platelet, and blood glucose levels within normal ranges

Patients who will stay in the intensive care unit for 14 days or longer

Disqualifiers

Patients who do not consent to participate in the study

Patients with severe nutritional problems and those who are cachectic

Patients with severe edema (+4 or above)

Patients with diabetes mellitus

Trial design

Design model

Parallel

Treatments tested in this trial

photobiomodulation
Device
The effectiveness of photobiomodulation application in chronic wound healing will be evaluated.

Treatment groups

46 Participants

are divided into 2 treatment groups

Group A: photobiomodulation groupExperimental treatment 1 intervention

Group B: control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

The healing of pressure sores in the patients in the experimental group will be faster and more effective than in the control group.

This application will be continued once a day for 14 days and wound evaluation will be made and wound photographs will be taken on days 1, 4, 7 and 14. Wound assessment will be based on Pressure Ulcer Scale for Healing-PUSH and wound measurement(diameter).

Time frame

14 days

Locations

This trial has no locations.

The Effect of Photobiomodulation on Pressure Ulcers